Characteristics for genetic screening have typically included onset before the age of 25–35 years, lack of insulin dependency (as shown by treatment or C‐peptide measurement), absence of obesity or other signs of insulin resistance, dominant inheritance over several generations and the absence of islet autoantibodies associated with type 1 diabetes.27 This evidence concerns the gene INS and Insulin resistance.